Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Group B Streptococcus (GBS) is a multiserotype bacterial pathogen representing a major cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we analyzed the genome sequences of eight GBS isolates and cloned and tested 312 surface proteins as vaccines. Four proteins elicited protection in mice, and their combination proved highly protective against a large panel of strains, including all circulating serotypes. Protection also correlated with antigen accessibility on the bacterial surface and with the induction of opsonophagocytic antibodies. Multigenome analysis and screening described here represent a powerful strategy for identifying potential vaccine candidates against highly variable pathogens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IsdA and IsdB were identified as vaccine candidates using “reverse vaccinology” [119], and subsequent studies confirmed that immunization with these proteins is protective in murine models of infection [117, 120–123].”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [119]
Citations
Cites
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Self-citationBaker, C. J., & Kasper, D. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941404 · Cited by 671
Self-citationMultilocus Sequence Typing System for Group B Streptococcus
Jones, N., Bohnsack, J. F., Takahashi, S., Oliver, K. A., Chan, M.-S., Kunst, F., Glaser, P., Rusniok, C., Crook, D. W. M., Harding, R. M., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2530-2536.2003 · Cited by 625
Tettelin, H., Masignani, V., Cieslewicz, M. J., Eisen, J. A., Peterson, S., Wessels, M. R., Paulsen, I. T., Nelson, K. E., Margarit, I., Read, T. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182380799 · Cited by 500
Self-citationCell wall sorting signals in surface proteins of gram‐positive bacteria.
Schneewind, O., Mihaylova‐Petkov, D., & Model, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06169.x · Cited by 426
Schuchat, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07128-1 · Cited by 386
Genome Analysis Reveals Pili in Group B Streptococcus
Lauer, P., Rinaudo, C. D., Soriani, M., Margarit, I., Maione, D., Rosini, R., Taddei, A. R., Mora, M., Rappuoli, R., Grandi, G., et al. (2005) · Science · doi:10.1126/science.1111563 · Cited by 317
Self-citationImmunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus
Baker, C. J., Rench, M. A., Edwards, M. S., Carpenter, R. J., Hays, B. M., & Kasper, D. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191802 · Cited by 296
Self-citationStålhammar-Carlemalm, M., Stenberg, L., & Lindahl, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1593 · Cited by 214
Serotypes VI and VIII Predominate among Group B Streptococci Isolated from Pregnant Japanese Women
Lachenauer, C. S., Kasper, D. L., Shimada, J., Ichiman, Y., Ohtsuka, H., Kaku, M., Paoletti, L. C., Ferrieri, P., & Madoff, L. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314666 · Cited by 204
Self-citation
Research works printed but not linked: 1
- 10.1053/siny.2002.0114 · doi:10.1053/siny.2002.0114
Cited by
Tettelin, H., Masignani, V., Cieslewicz, M. J., Donati, C., Medini, D., Ward, N. L., Angiuoli, S. V., Crabtree, J., Jones, A. L., Durkin, A. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506758102 · Cited by 2,631
Self-citationMedini, D., Donati, C., Tettelin, H., Masignani, V., & Rappuoli, R. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.09.006 · Cited by 1,299
Self-citationThe significance of infection related to orthopedic devices and issues of antibiotic resistance
Campoccia, D., Montanaro, L., & Arciola, C. R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.044 · Cited by 1,109
BPGA- an ultra-fast pan-genome analysis pipeline
Chaudhari, N. M., Gupta, V. K., & Dutta, C. (2016) · Scientific Reports · doi:10.1038/srep24373 · Cited by 988
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Self-citationSortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria
Marraffini, L. A., DeDent, A. C., & Schneewind, O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.192-221.2006 · Cited by 686
Streptococcus Adherence and Colonization
Nobbs, A. H., Lamont, R. J., & Jenkinson, H. F. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-09 · Cited by 657
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Sette, A., & Rappuoli, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.017 · Cited by 559
Self-citationPili in Gram-negative and Gram-positive bacteria — structure, assembly and their role in disease
Proft, T., & Baker, E. N. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8477-4 · Cited by 547
Pili in Gram-positive pathogens
Telford, J. L., Barocchi, M. A., Margarit, I., Rappuoli, R., & Grandi, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1443 · Cited by 454
Self-citationIncreasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007
Skoff, T. H., Farley, M. M., Petit, S., Craig, A. S., Schaffner, W., Gershman, K., Harrison, L. H., Lynfield, R., Mohle‐Boetani, J., Zansky, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599369 · Cited by 452
Rodríguez-Ortega, M. J., Norais, N., Bensi, G., Liberatori, S., Capo, S., Mora, M., Scarselli, M., Doro, F., Ferrari, G., Garaguso, I., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1179 · Cited by 433
Self-citationPili in Gram-positive bacteria: assembly, involvement in colonization and biofilm development
Mandlik, A., Swierczynski, A., Das, A., & Ton-That, H. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.10.010 · Cited by 402
Dziva, F., & Stevens, M. P. (2008) · Avian Pathology · doi:10.1080/03079450802216652 · Cited by 392
Mora, M., Bensi, G., Capo, S., Falugi, F., Zingaretti, C., Manetti, A. G. O., Maggi, T., Taddei, A. R., Grandi, G., & Telford, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507808102 · Cited by 387
Self-citationMicrobiology in the post-genomic era
Medini, D., Serruto, D., Parkhill, J., Relman, D. A., Donati, C., Moxon, R., Falkow, S., & Rappuoli, R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1901 · Cited by 358
Self-citationGroup B Streptococcus: global incidence and vaccine development
Johri, A. K., Paoletti, L. C., Glaser, P., Dua, M., Sharma, P. K., Grandi, G., & Rappuoli, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1552 · Cited by 333
Self-citationSerotype IX, a Proposed New Streptococcus agalactiae Serotype
Slotved, H., Kong, F., Lambertsen, L. M., Sauer, S., & Gilbert, G. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00117-07 · Cited by 331
Genome Analysis Reveals Pili in Group B Streptococcus
Lauer, P., Rinaudo, C. D., Soriani, M., Margarit, I., Maione, D., Rosini, R., Taddei, A. R., Mora, M., Rappuoli, R., Grandi, G., et al. (2005) · Science · doi:10.1126/science.1111563 · Cited by 317
Self-citationVaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
The Current State of Poststreptococcal Glomerulonephritis
Rodriguez-Iturbe, B., & Musser, J. M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010092 · Cited by 296
Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology
Shabayek, S., & Spellerberg, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00437 · Cited by 291
Giefing, C., Meinke, A. L., Hanner, M., Henics, T., Minh, D. B., Gelbmann, D., Lundberg, U., Senn, B. M., Schunn, M., Habel, A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071168 · Cited by 271
Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 256
Assembly and role of pili in group B streptococci
Dramsi, S., Caliot, E., Bonne, I., Guadagnini, S., Prévost, M., Kojadinovic, M., Lalioui, L., Poyart, C., & Trieu‐Cuot, P. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05190.x · Cited by 252
Rosini, R., Rinaudo, C. D., Soriani, M., Lauer, P., Mora, M., Maione, D., Taddei, A., Santi, I., Ghezzo, C., Brettoni, C., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05225.x · Cited by 239
Self-citationPreventing Bacterial Infections with Pilus-Based Vaccines: the Group B Streptococcus Paradigm
Margarit, I., Rinaudo, C. D., Galeotti, C. L., Maione, D., Ghezzo, C., Buttazzoni, E., Rosini, R., Runci, Y., Mora, M., Buccato, S., et al. (2009) · Journal of Infectious Diseases · doi:10.1086/595564 · Cited by 235
Self-citationUnderstanding the Regulation of Group B Streptococcal Virulence Factors
Rajagopal, L. (2009) · Future Microbiology · doi:10.2217/17460913.4.2.201 · Cited by 216
Developing vaccines in the era of genomics: a decade of reverse vaccinology
Seib, K. L., Zhao, X., & Rappuoli, R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03939.x · Cited by 215
Self-citationSchijns, V. E., & Lavelle, E. C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.21 · Cited by 211
Genomic diversity and evolution within the species Streptococcus agalactiae
Brochet, M., Couvé, E., Zouine, M., Vallaeys, T., Rusniok, C., Lamy, M.-C., Buchrieser, C., Trieu-Cuot, P., Kunst, F., Poyart, C., et al. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.11.010 · Cited by 206
From empiricism to rational design: a personal perspective of the evolution of vaccine development
De Gregorio, E., & Rappuoli, R. (2014) · Nature Reviews Immunology · doi:10.1038/nri3694 · Cited by 204
Self-citationThe Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases
Seib, K. L., Dougan, G., & Rappuoli, R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000612 · Cited by 203
Self-citationMaisey, H. C., Hensler, M., Nizet, V., & Doran, K. S. (2007) · Journal of Bacteriology · doi:10.1128/jb.01153-06 · Cited by 201
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 199
Jordan, H. T., Farley, M. M., Craig, A., Mohle-Boetani, J., Harrison, L. H., Petit, S., Lynfield, R., Thomas, A., Zansky, S., Gershman, K., et al. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318180b3b9 · Cited by 193
Pili with strong attachments: Gram‐positive bacteria do it differently
Scott, J. R., & Zähner, D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05279.x · Cited by 192
A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta
Whidbey, C., Harrell, M. I., Burnside, K., Ngo, L., Becraft, A. K., Iyer, L. M., Aravind, L., Hitti, J., Adams Waldorf, K. M., & Rajagopal, L. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122753 · Cited by 188
Bagnoli, F., Moschioni, M., Donati, C., Dimitrovska, V., Ferlenghi, I., Facciotti, C., Muzzi, A., Giusti, F., Emolo, C., Sinisi, A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00384-08 · Cited by 187
Self-citationFitzgerald, J. R. (2009) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2009.00828.x · Cited by 186
The contribution of immunology to the rational design of novel antibacterial vaccines
Kaufmann, S. H. E. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1688 · Cited by 186
Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome
Beres, S. B., & Musser, J. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000800 · Cited by 181
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections
O'Brien, V. P., Hannan, T. J., Nielsen, H. V., & Hultgren, S. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.uti-0013-2012 · Cited by 180
Harnessing bioinformatics to discover new vaccines
Davies, M. N., & Flower, D. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.010 · Cited by 179
Maize (Zea mays L.) Genome Diversity as Revealed by RNA-Sequencing
Hansey, C. N., Vaillancourt, B., Sekhon, R. S., de León, N., Kaeppler, S. M., & Buell, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033071 · Cited by 178
Vaccines, Reverse Vaccinology, and Bacterial Pathogenesis
Delany, I., Rappuoli, R., & Seib, K. L. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012476 · Cited by 177
Self-citationThe use of genomics in microbial vaccine development
Bambini, S., & Rappuoli, R. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.007 · Cited by 173
Self-citationMandlik, A., Swierczynski, A., Das, A., & Ton‐That, H. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05630.x · Cited by 172
Structure-based antigen design: a strategy for next generation vaccines
Dormitzer, P. R., Ulmer, J. B., & Rappuoli, R. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.08.002 · Cited by 169
Self-citationHe, Y. O., Rappuoli, R., Groot, A. S. D., & Chen, R. T. (2010) · BioMed Research International · doi:10.1155/2010/218590 · Cited by 168
Self-citationStructural Basis of Host Cell Recognition by the Pilus Adhesin from Streptococcus pneumoniae
Izoré, T., Contreras‐Martel, C., Mortaji, L. E., Manzano, C., Terrasse, R., Vernet, T., Guilmi, A. M. D., & Dessen, A. (2010) · Structure · doi:10.1016/j.str.2009.10.019 · Cited by 168
Streptococcus suisEnolase Functions as a Protective Antigen Displayed on the Bacterial Cell Surface
Feng, Y., Pan, X., Sun, W. Y., Wang, C., Zhang, H., Li, X., Ma, Y., Shao, Z., Ge, J., Zheng, F., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644602 · Cited by 165
Nuccitelli, A., Cozzi, R., Gourlay, L. J., Donnarumma, D., Necchi, F., Norais, N., Telford, J. L., Rappuoli, R., Bolognesi, M., Maione, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106590108 · Cited by 163
Self-citationStreptococcus pneumoniae Pilus Subunits Protect Mice against Lethal Challenge
Gianfaldoni, C., Censini, S., Hilleringmann, M., Moschioni, M., Facciotti, C., Pansegrau, W., Masignani, V., Covacci, A., Rappuoli, R., Barocchi, M. A., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01400-06 · Cited by 162
Self-citationRinaudo, C. D., Telford, J. L., Rappuoli, R., & Seib, K. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38330 · Cited by 160
Self-citationPatterns of antigenic diversity and the mechanisms that maintain them
Lipsitch, M., & O’Hagan, J. J. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.0229 · Cited by 159
Designing and building the next generation of improved vaccine adjuvants
Brito, L. A., & O'Hagan, D. T. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.027 · Cited by 158
Post‐genomic vaccine development
Serruto, D., & Rappuoli, R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.084 · Cited by 158
Self-citationRrgA is a pilus‐associated adhesin in Streptococcus pneumoniae
Nelson, A. L., Ries, J., Bagnoli, F., Dahlberg, S., Fälker, S., Rounioja, S., Tschöp, J., Morfeldt, E., Ferlenghi, I., Hilleringmann, M., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05908.x · Cited by 157
Self-citationDevelopmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection
Lewis, D. B., & Wilson, C. B. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50006-2 · Cited by 157
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity
Cassat, J. E., & Skaar, E. P. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0294-4 · Cited by 155
“IsdA and IsdB were identified as vaccine candidates using “reverse vaccinology” [119], and subsequent studies confirmed that immunization with these proteins is protective in murine models of infection [117, 120–123].”
BackgroundGroup B Streptococcal Infections
Randis, T. M., Baker, J. A., & Ratner, A. J. (2017) · Pediatrics in Review · doi:10.1542/pir.2016-0127 · Cited by 153
Maruggi, G., Chiarot, E., Giovani, C., Buccato, S., Bonacci, S., Frigimelica, E., Margarit, I., Geall, A., Bensi, G., & Maione, D. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.040 · Cited by 149
Self-citationComputer aided selection of candidate vaccine antigens
Flower, D. R., Macdonald, I. K., Ramakrishnan, K., Davies, M. N., & Doytchinova, I. A. (2010) · Immunome Research · doi:10.1186/1745-7580-6-s2-s1 · Cited by 144
Banerjee, A., Kim, B. J., Carmona, E. M., Cutting, A. S., Gurney, M. A., Carlos, C., Feuer, R., Prasadarao, N. V., & Doran, K. S. (2011) · Nature Communications · doi:10.1038/ncomms1474 · Cited by 142
Berlanda Scorza, F., Doro, F., Rodríguez-Ortega, M. J., Stella, M., Liberatori, S., Taddei, A. R., Serino, L., Gomes Moriel, D., Nesta, B., Fontana, M. R., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700295-mcp200 · Cited by 140
Self-citationThe pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterials
Muzzi, A., Masignani, V., & Rappuoli, R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.04.008 · Cited by 140
Self-citationNERVE: New Enhanced Reverse Vaccinology Environment
Vivona, S., Bernante, F., & Filippini, F. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-35 · Cited by 140
Bensi, G., Mora, M., Tuscano, G., Biagini, M., Chiarot, E., Bombaci, M., Capo, S., Falugi, F., Manetti, A. G. O., Donato, P., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015693 · Cited by 139
Self-citationPerinatal Streptococcus agalactiae Epidemiology and Surveillance Targets
Furfaro, L. L., Chang, B. J., & Payne, M. S. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-18 · Cited by 138
Group B Streptococcus vaccine: state of the art
Nuccitelli, A., Rinaudo, C. D., & Maione, D. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615579869 · Cited by 137
Self-citationSanti, I., Scarselli, M., Mariani, M., Pezzicoli, A., Masignani, V., Taddei, A., Grandi, G., Telford, J. L., & Soriani, M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05555.x · Cited by 135
Self-citationComputer-aided biotechnology: from immuno-informatics to reverse vaccinology
Vivona, S., Gardy, J. L., Ramachandran, S., Brinkman, F. S. L., Raghava, G. P. S., Flower, D. R., & Filippini, F. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.12.006 · Cited by 135
Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus
Rinaudo, C. D., Rosini, R., Galeotti, C. L., Berti, F., Necchi, F., Reguzzi, V., Ghezzo, C., Telford, J. L., Grandi, G., & Maione, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009216 · Cited by 135
Self-citationUropathogenic Escherichia coli Mediated Urinary Tract Infection
Totsika, M., Gomes Moriel, D., Idris, A., A. Rogers, B., J. Wurpel, D., Phan, M.-D., L. Paterson, D., & A. Schembri, M. (2012) · Current Drug Targets · doi:10.2174/138945012803530206 · Cited by 132
Development of Streptococcus agalactiae vaccines for tilapia
Liu, G., Zhu, J., Chen, K., Gao, T., Yao, H., Liu, Y., Zhang, W. Y., & Lu, C. (2016) · Diseases of Aquatic Organisms · doi:10.3354/dao03084 · Cited by 131
Gao, X., Zhi, X., Li, H.-W., Klenk, H., & Li, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101229 · Cited by 131
Falugi, F., Zingaretti, C., Pinto, V., Mariani, M., Amodeo, L., Manetti, A. G. O., Capo, S., Musser, J. M., Orefici, G., Margarit, I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/593176 · Cited by 126
Self-citationTh17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Wu, W., Huang, J., Duan, B., Traficante, D. C., Hong, H., Risech, M., Lory, S., & Priebe, G. P. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0182oc · Cited by 124
Seifert, K. N., Adderson, E. E., Whiting, A. A., Bohnsack, J. F., Crowley, P. J., & Brady, L. J. (2006) · Microbiology · doi:10.1099/mic.0.28516-0 · Cited by 122
Vernikos, G. S., & Medini, D. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000162 · Cited by 121
The past, current and future trends in DNA vaccine immunisations
Hasson, S. S., Al-Busaidi, J. Z., & Sallam, T. A. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30366-x · Cited by 119
Vaccinology at the beginning of the 21st century
Wack, A., & Rappuoli, R. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.005 · Cited by 119
Self-citationDesigning Vaccines for the Twenty-First Century Society
Finco, O., & Rappuoli, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00012 · Cited by 118
Self-citationBacterial genome sequencing and its use in infectious diseases
Fournier, P., Drancourt, M., & Raoult, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70260-8 · Cited by 117
Group B Streptococcus and pregnancy: a review
Larsen, J. W., & Sever, J. L. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.11.030 · Cited by 116
Reverse vaccinology in the 21st century: improvements over the original design
Donati, C., & Rappuoli, R. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12046 · Cited by 115
Self-citationStructural and Computational Biology in the Design of Immunogenic Vaccine Antigens
Liljeroos, L., Malito, E., Ferlenghi, I., & Bottomley, M. J. (2015) · Journal of Immunology Research · doi:10.1155/2015/156241 · Cited by 115
McGee, L., Chochua, S., Li, Z., Mathis, S., Rivers, J., Metcalf, B. J., Ryan, A., Alden, N. B., Farley, M. M., Harrison, L. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa151 · Cited by 113
Surfome Analysis as a Fast Track to Vaccine Discovery
Doro, F., Liberatori, S., Rodríguez‐Ortega, M. J., Rinaudo, C. D., Rosini, R., Mora, M., Scarselli, M., Altındiş, E., D’Aurizio, R., Stella, M., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800486-mcp200 · Cited by 111
Self-citationGroup B streptococcal epidemiology and vaccine needs in developed countries
Melin, P., & Efstratiou, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.012 · Cited by 108
A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence
Maisey, H. C., Quach, D., Hensler, M. E., Liu, G. Y., Gallo, R. L., Nizet, V., & Doran, K. S. (2008) · The FASEB Journal · doi:10.1096/fj.07-093963 · Cited by 106
Sortase-Mediated Pilus Fiber Biogenesis in Streptococcus pneumoniae
Manzano, C., Contreras‐Martel, C., Mortaji, L. E., Izoré, T., Fenel, D., Vernet, T., Schoehn, G., Guilmi, A. M. D., & Dessen, A. (2008) · Structure · doi:10.1016/j.str.2008.10.007 · Cited by 106
A maternal vaccine against group B Streptococcus: Past, present, and future
Chen, V. L., Avci, F. Y., & Kasper, D. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.080 · Cited by 104
Self-citationMartins, E., Pessanha, M. A., Ramirez, M., & Melo‐Cristino, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01182-07 · Cited by 104
Vaccines in the era of genomics: The pneumococcal challenge
Barocchi, M. A., Censini, S., & Rappuoli, R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.065 · Cited by 103
Self-citationNuccitelli, A., Rinaudo, C. D., Brogioni, B., Cozzi, R., Ferrer‐Navarro, M., Yero, D., Telford, J. L., Grandi, G., Daura, X., Zacharias, M., et al. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003115 · Cited by 103
Self-citationNallapareddy, S. R., Sillanpää, J., Mitchell, J., Singh, K. V., Chowdhury, S. A., Weinstock, G. M., Sullam, P. M., & Murray, B. E. (2011) · Infection and Immunity · doi:10.1128/iai.00039-11 · Cited by 103
Bröker, M., Berti, F., Schneider, J., & Vojtek, I. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.078 · Cited by 103
Singh, R., Capalash, N., & Sharma, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12789-3 · Cited by 102
Metadata
- Authors
- Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., Rosini, R., D'Agostino, N., Miorin, L., Buccato, S., Mariani, M., Galli, G., Nogarotto, R., Nardi-Dei, V., Vegni, F., Fraser, C., Mancuso, G., Teti, G., Madoff, L. C., Paoletti, L. C., Rappuoli, R., Kasper, D. L., Telford, J. L., & Grandi, G.
- Affiliations
- University of Messina (IT)
- Chiron srl, Via Fiorentina 1, 53100 Siena, Italy.
- Corresponding author
- Maione, Domenico
- Margarit, Immaculada
- Grandi, Guido
- ORCID
- Venue
- Science
- Published
- 2005-07
- Volume
- 309
- Issue
- 5731
- Pages
- 148-150
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC1351092
- OpenAlex
- W2139049032
- Cited by
- 556
- References
- 18
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 21 · 2019: 16 · 2018: 22 · 2017: 27 · 2016: 34 · 2015: 27 · 2014: 32 · 2013: 29 · 2012: 34
- FWCI
- 38.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI 060603, U01AI060603)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- Streptococcus agalactiae, vaccine candidate identification, surface proteins, neonatal infection
- MeSH terms
- Animals, Animals, Newborn, Antibodies, Bacterial, Antigens, Bacterial, Antigens, Surface, Bacterial Proteins, Female, Humans, Immunity, Maternally-Acquired, Neutrophils, Opsonin Proteins, Phagocytosis, Serotyping, Streptococcal Infections, Streptococcus agalactiae, Vaccination, Genome, Bacterial, Computational Biology, Streptococcal Vaccines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.